Search company, investor...

Coulter Pharmaceutical

Total Raised

$43.1M

Investors Count

19

Deal Terms

2

Funding, Valuation & Revenue

8 Fundings

Coulter Pharmaceutical's latest funding round was a Acq - P2P for on December 20, 2000.

Coulter Pharmaceutical's valuation in January 1997 was $120.12M.

Coulter Pharmaceutical's latest post-money valuation is from December 2000.

Sign up for a free trial to see Coulter Pharmaceutical's valuations in December 2000 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/20/2000

Acq - P2P

$99M

0

FY undefined

1

8/14/2000

PIPE

$99M

0

FY undefined

0

1/28/1997

IPO

$99M

$120.12M

0

FY undefined

0

1/1/1997

Unattributed - II

$99M

0

FY undefined

0

4/1/1996

Unattributed

$99M

0

FY undefined

0

Date

12/20/2000

8/14/2000

1/28/1997

1/1/1997

4/1/1996

Round

Acq - P2P

PIPE

IPO

Unattributed - II

Unattributed

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$120.12M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

0

0

0

0

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Coulter Pharmaceutical Deal Terms

2 Deal Terms

Coulter Pharmaceutical's deal structure is available for 2 funding rounds, including their Acq - P2P from December 20, 2000.

Round

Acq - P2P

IPO

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acq - P2P

$99M

$99M

$99M

$99M

IPO

$99M

$99M

$99M

$99M

$99M

$99M

Coulter Pharmaceutical Investors

19 Investors

Coulter Pharmaceutical has 19 investors. Corixa invested in Coulter Pharmaceutical's Acq - P2P funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/20/2000

12/20/2000

1
Acq - P2P

Corporation

Washington

8/14/2000

8/14/2000

1
PIPE

Corporation

Massachusetts

8/14/2000

8/14/2000

1
PIPE

00/00/0000

00/00/0000

Narragansett Asset Management

Subscribe to see more

Asset/Investment Management

Connecticut

00/00/0000

00/00/0000

J.P. Morgan Chase & Co.

Subscribe to see more

Diversified Financial Services

New York

First funding

12/20/2000

8/14/2000

8/14/2000

00/00/0000

00/00/0000

Last Funding

12/20/2000

8/14/2000

8/14/2000

00/00/0000

00/00/0000

Investor

Narragansett Asset Management

J.P. Morgan Chase & Co.

Rounds

1
Acq - P2P
1
PIPE
1
PIPE

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Asset/Investment Management

Diversified Financial Services

Location

Washington

Massachusetts

Connecticut

New York

Compare Coulter Pharmaceutical to Competitors

L
Ligon Discovery

Ligon Discovery is a drug discovery company built around the firm's primary technology platform, Small-Molecule Microarrays (SMMs).

B
Brain Tunnelgenix Technologies

Brain Tunnelgenix Technologies provides medical devices and equipment services. It offers non-invasive and continuous wearable technology that tracks human brain temperature through the brain's thermal tunnel. Brain Tunnelgenix Technologies was founded in 2006 and is based in Aventura, Florida.

M
Mercator MedSystems

Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.

R
Rafael Medical Technologies

Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.

L
LifePoint

Lifepoint is a medical technology company developing rapid and cost effective, non-invasive, on-site diagnostic products. The Company has developed and will continue to develop patented, proprietary technologies utilizing saliva as a test specimen to provide blood equivalent diagnostic results without the need for blood or urine.

T
TrueVision Systems

TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.